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Ethical approval for national studies in Ireland: an illustration of current 
challenges 
 
Abstract 
Background: Ethical approval of research projects is, appropriately, an essential 
prerequisite in health settings. 
Aims: This paper outlines difficulties encountered with procedures for gaining ethical 
approval for two multi-centre surveys in Ireland. 
Method: The experiences of two national surveys are compared. 
Results: Delays in processing ethics applications led to substantial delay in both 
surveys. Research Ethics Committees assessed applications in an idiosyncratic 
manner. 
Conclusion: In Ireland, there is currently no accepted mechanism for single location 
ethical approval for multi-centre studies. Instead, they require separate approval from 
all participating centres. The challenges of this system of application to multiple 
committees are outlined in this paper, and possible solutions presented. 
 
 
Introduction 
Evidence-based practice is informed by research. Health services research provides 
policy makers and service providers with information to plan for healthcare needs and 
for service evaluation. Health research involves finding the evidence for best practice 
and may be distinguished from audit, which addresses whether best practice is being 
followed. Ethical review of health services research is entirely appropriate and serves 
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the interest of the general public, funding agencies and the broad research 
community. The process of requiring ethical approval has expanded very rapidly from 
coverage of clinical trials only, to coverage of all human and animal research. At 
present, Research Ethics Committees (RECs) may distinguish between clinical trials 
and other human or animal research (such as health services research and audit). In 
practice however, most of the RECs preside over both clinical trials and other 
research submitted for approval, including audit. Audit, while not strictly research, is 
often undertaken as a research-type activity and will use staff time and resources. 
Institutions differ in the extent to which they require ethical evaluation of audit-type 
projects. In some institutions, there may be a wish to have documented such 
information-gathering work which is conducted on an irregular basis. 
 
RECs have only recently been established in many centres and there appears to be 
significant variation in their modes of operation. For example, some RECs require the 
investigators to attend REC meetings. Of concern is the fact that conflicting decisions 
can be taken by different committees considering the same or similar research 
protocols. The time taken to obtain ethical approval for multi-centre studies is also a 
concern. This problem is not unique to Ireland1. The European Union (EU) is working 
to establish formal procedures and time limits for ethics submission and review2.  
This paper provides examples from our recent experience to illustrate areas of 
concern, to foster discussion of the challenges among researchers in Ireland and to 
consider some possible solutions. 
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Two studies recently undertaken by the Health Services Research Centre (HSRC) at 
the Royal College of Surgeons in Ireland (RCSI) involved data collection in national 
samples of hospitals. One study was a national evaluation of the management of acute 
coronary syndromes in all 39 hospitals providing cardiac services. The other was a 
staff survey of attitudes to organ donation. It was conducted in all relevant 37 public 
hospitals nationally. There is currently no single centre or group who can provide 
ethical approval that is acceptable across hospitals nationally.  Both studies applied to 
and were given ethical approval by the RCSI REC. Researchers then contacted all 
potentially participating hospitals and asked about their ethics review procedures. 
They noted that the study had already received overall ethical approval from the 
RCSI REC. Details relating to processing the project at the various centres throughout 
Ireland are presented in table 1.  
 
    - Table 1 about here -  
 
 
A number of idiosyncratic requests arose in the process of seeking ethical approval. 
In one hospital, the staff survey protocol was sent to both the REC and a patient-
focused hospital liaison committee. While the REC provided approval, the patient-
focused committee requested a number of changes to the (staff-only) interview 
schedule. In another hospital, REC approval was granted but the researcher was 
subsequently (informally) notified that approval was also needed from an internal 
research access committee who aimed to evaluate the level of staff input required to 
facilitate studies.  This committee was not mentioned in correspondence by the 
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hospital’s chief executive or REC. Its existence only became evident when plans to 
implement the study at ward level were initiated. Approval from a risk management 
group was required following REC approval at another centre. In another centre, one 
local sponsoring consultant physician was required to make a Designated Research 
Application before the researcher could seek REC approval. Two hospital executive 
committees and two senior consultants considered the question of acceptability of the 
study in two hospitals where RECs also operated. Finally, one consultant continued to 
insist that the local hospital REC provide evaluation (rather than the Health Board 
REC), despite confirmation from the relevant CEO’s office that the hospital in 
question did not have a local REC. 
 
Most centres had their own application form. While there were similarities across 
centres, the process of completing multiple application forms was a time-consuming 
one. In many cases, it was difficult to find out who to contact for details of the 
hospital’s REC procedures and forms, when the next REC meeting was scheduled 
and whether the researcher needed to attend. Other sources of delay in processing 
applications including postponement of scheduled REC meetings.  
 
One application took fully seven months to process, because of various administrative 
difficulties. Obviously, this is a significant strain on a project in terms of resources 
and logistics. An estimate of researcher time required to process ethics applications 
alone in a multi-centre project is surprising – our estimate is a two month full-time 
equivalent period but with the workload extending across approximately a 5 month 
timeframe: between time taken to complete different forms; contacting committees 
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for individual arrangements; travelling to committees to attend meetings; 
resubmissions; re-contact for other required procedures/committees, etc. Ultimately 
all ethics committee applications for the two projects were approved.  
 
The time that may be required to obtain ethical approval is an important concern for 
researchers and research funders. Failure to predict and ‘cost’ for the time required 
for completion of the REC approval process can result in overruns and even 
abandonment of otherwise sound projects in relevant centres. The time required is 
likely to be either underestimated by researchers and/or considered excessive if 
requested in grant applications by reviewers.  
 
That acquiring ethical approval should be so fraught with difficulties is not inevitable 
but rather suggests the system for REC approval itself requires review. Some 
observations from our experiences in conducting the studies presented above are 
illustrative of how the system for REC approval has failed to keep pace with the 
increasing demands made upon it. 
 
Firstly, the administrative tasks associated with REC appear to be poorly supported. 
In our experience only one REC had dedicated secretarial/clerical support. Most 
operated with the REC chairperson (usually a senior hospital consultant) supported by 
a member of hospital staff (frequently a professional employed in the hospital 
laboratory setting), with clerical services supplied on an ad hoc basis by personnel 
from various work areas within the hospital. Tracking the progress of applications is 
difficult. In many cases, personnel from clinical and laboratory services within 
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hospitals appeared to have responsibility for progressing applications and supporting 
RECs. It is assumed that this is in addition to their routine tasks, which given the 
workload in most hospital departments today, allows little scope for added duties. 
 
Secondly, application forms for ethical review are generally formulated in the 
‘clinical trial’ model. Many RECs were set up specifically under the Clinical Trials 
Act (1987). This format is ill-suited to a wider programme of research activity. In our 
experience, completing the documentation and meeting the stated requirements based 
on the ‘clinical trial model’ presented a number of difficulties: 
• Much of the information requested is inappropriate in the context of health 
services research. 
• There is often a requirement that the principal investigator (PI) is a hospital 
consultant.  This may be inappropriate in the context of service research and 
indeed has the potential to introduce bias where a project is effectively reliant 
on ‘sponsorship’ by a service which is being assessed or investigated. The 
requirement for a named PI from a hospital in one of our studies resulted in all 
correspondence relating to the project being routed through this local 
consultant (nominated and agreeing to act as PI to facilitate progress). This 
caused considerable confusion, delay to the project and inconvenience to the 
consultant. 
 
Finally, RECs may take on a role, or be required to act in a manner, that goes beyond 
consideration of ethical concerns. One area which this is evident is comment on study 
methodology. It is of course the case that poor methodology makes for bad science. 
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Quite appropriately there are ethical concerns in approving a methodologically flawed 
study. In our experience however, some questions raised by RECs showed poor 
comprehension of methodological issues, or a willingness to propose alternative or 
‘preferred’ methodological strategies. For instance, one REC in the group described 
initially required (and later retracted following correspondence) alterations to the 
methodology in a manner that would have compromised its scientific integrity. In 
conducting multi-centre studies with single institutional RECs, it is particularly 
important that the undertakings of the RECs should be restricted to the review of 
ethical considerations. 
 
A number of recommendations can be proposed from the observations above. Firstly, 
the composition of an REC needs to be tailored to the topics/disciplines being 
assessed. Individuals with expertise/experience in the research methods to be used in 
the submitted research are needed. Since the RECs under consideration are hospital-
based committees, there has typically been a preponderance of clinical medical 
personnel on such groups. Epidemiological and social science members are 
increasingly needed to assess the wider range of projects submitted to RECs. 
Secondly, consideration should be given to the development of national guidelines for 
the operation of RECs. A single national REC is an attractive option but likely to be 
unmanageable in terms of the time requirement for staff or the legal responsibilities 
they would face. However, this option may be required if the recent EU directive2 is 
implemented fully. Directive 2001/20/EC may restrict the volume of research being 
conducted. It is also likely that several types of research (e.g. research on 
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incapacitated participants) will become increasingly difficult to conduct, as proxy 
consent of a legal representative will be required.3 
 
A more manageable option may be a system of mutual acceptance of approval across 
centres for multi-centre studies (this would be facilitated if centres were committed to 
national guidelines). Another system would be for centres to focus on specific types 
of ethical application, e.g. animal research. Approval is now required from single 
RECs for projects as diverse as hospital-based clinical trials, community health 
studies and animal research. These options need to be discussed in open fora if 
progress is to be made. The most acceptable organisers of such discussions are likely 
to be the research funding agencies, and we understand some developments are 
already underway. This whole issue is all the more important given changing 
requirements for data protection from the EU and from the Data Protection 
(Amendment) Act 2003. 
 
In essence, we are currently at a juncture where the currently considerable efforts of 
many individuals to provide ethical review of research projects needs some 
coordination and rationalisation if the system is to remain manageable for those 
providing, using and funding it. 
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Table 1. Profile of the research ethics committee requirements to conduct national 
studies: two recent Irish projects 
Study feature Study 1 
Barriers to organ donation in 
Ireland: ICU staff survey 
Study 2 
Hospital management of acute 
coronary syndromes in Ireland 
Study format Descriptive survey of staff 
attitudes 
Patient chart data and patient self-
report data 
Data gathering instrument Anonymous postal 
questionnaire distributed to 
relevant staff by Human 
Resources Departments of 
hospitals 
Patient chart data and patient 
completion of self-report 
questionnaire.  Patient ‘s name 
and permission for re-contact 12 
months later were also requested 
Funding body Health Research Board Department of Health & Children 
Timeframe for data collection 2001-2003 2003 
Number of hospitals included 37 39 
Initial contact Letter to hospital chief 
executive officer (CEO) 
introducing study and asking 
about requirements for local 
Research Ethics Committee 
approval (REC) 
Letter to CEO. Subsequent 
telephone contact asking about 
REC considerations. Decision 
taken to submit protocol to each 
committee individually as lack of 
clarity and delays regarding same 
Subsequent contact Referral to appropriate REC Correspondence to RECs 
Outcome 
Hospital required application 
to individual hospital REC on 
their standard form 
13 (two of these required re-
submission) 
13 (1 Committee covered 2 
hospitals, another covered 8 
hospitals) 
Health board REC (N=8 health 
board authorities) 
2 
(2 boards which covered 3 
relevant hospitals) 
4 
(4 boards which covered 15 
relevant hospitals) 
Informal approval/Approval by 
hospital CEO’s office.  
21 
 
3 
*Submissions to other 
committees or individuals 
required following local or 
regional REC approval** 
6 2 
Researcher attendance at REC 
required 
4 3 (plus 2 additional sites where 
local consultant/PI was required 
to attend) 
*details given in text of paper 
**these are in addition to overall research approval by researcher institutions REC. 
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